Conditions: Staphylococcal Skin Infections
Keywords: Complicated Skin and Skin-Structure Infections, Daptomycin, MRSA, Diabetic Foot, Abscess, Cellulitis Complicated skin and skin-structure infections
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 52
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults

Detailed description:

Arms:
arm 1: 350 mg of Daptomycin was supplied as sterile lyophilized powder in glass vials. Each vial was to be reconstituted with 7 mL of normal saline or water for injection, to give a 50 mg/mL drug concentration. Daptomycin was to be administered as a 30-minute intravenous infusion, once daily for at least 7 days, at the dose of 4 mg/Kg, up to a maximum of 14 days.

Interventions: intervention 1: Daptomycin
Intervention descriptions: intervention 1: None

Protocol document: